Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LH - Labcorp Holdings Inc.


235.65
-1.180   -0.501%

Share volume: 505,066
Last Updated: 03-13-2025
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$236.83
-1.18
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
27%
Profitability 18%
Dept financing 14%
Liquidity 21%
Performance 41%
Company vs Stock growth
vs
Performance
5 Days
-3.47%
1 Month
-6.51%
3 Months
-6.51%
6 Months
-6.51%
1 Year
-6.51%
2 Year
-6.51%
Key data
Stock price
$235.65
P/E Ratio 
27.13
DAY RANGE
$234.31 - $237.81
EPS 
$1.72
52 WEEK RANGE
$230.98 - $258.59
52 WEEK CHANGE
-$6.51
MARKET CAP 
20.237 B
YIELD 
0.94%
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$856,895
AVERAGE 30 VOLUME 
$745,742
Company detail
CEO: Adam H. Schechter
Region: US
Website: labcorp.com
Employees: 75,500
IPO year: 1990
Issue type:
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, and prostate-specific antigens. The company also provides specialty testing services, including gene-based and esoteric testing.

Recent news